Hysbysiad gwybodaeth ymlaen llaw
Hysbysiad gwybodaeth ymlaen llaw yn unig yw hwn
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Betsi Cadwaladr University Health Board
Headquarters Ysbyty Gwynedd, Penrhosgarnedd
Bangor
LL57 2PW
UK
E-bost: nwssp.procurementcataloguepathology@wales.nhs.uk
NUTS: UK
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://bcuhb.nhs.wales/
Cyfeiriad proffil y prynwr: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.2) Caffael ar y cyd
Caiff y contract ei ddyfarnu gan gorff prynu canolog
I.3) Cyfathrebu
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Pathology Testing Services for HFE Genes
Cyfeirnod: BCU-MSPP-63287
II.1.2) Prif god CPV
85111800
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
Betsi Cadwaladr University Health Board intends to follow the Most Suitable Provider Process to award a contract for the provision of Pathology Testing Services for HFE Genes including extraction
II.1.5) Cyfanswm gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 65 000.00 GBP
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
85100000
85111810
II.2.3) Man cyflawni
Cod NUTS:
UKL
II.2.4) Disgrifiad o’r caffaeliad
This is a Provider Selection Regime (PSR) Intended Approach Notice.
Betsi Cadwaladr University Health Board (BCUHB) intends to follow the Most Suitable Provider Process under The Health Services (Provider Selection Regime) (Wales) Regulations 2025 for the provision of outsourced pathology testing services for HFE genes, including sample extraction.
In accordance with the Most Suitable Provider Process, the Contracting Authority has considered which providers are capable of delivering the service and, having regard to the key criteria and all relevant information available at this time, considers that it is able to identify the most suitable provider to deliver the requirement.
The Contracting Authority intends to award a single contract to the most suitable provider. This Intended Approach Notice will be published for a period of at least 14 days, allowing interested parties the opportunity to raise any enquiries or provide relevant information for consideration before a contract award decision is made.
II.2.14) Gwybodaeth ychwanegol
This is a Provider Selection Regime (PSR) Intended Approach Notice. The contract is subject to The Health Services (Provider Selection Regime) (Wales) Regulations 2025 and is intended to be awarded using the Most Suitable Provider Process. Award decisions will be made by the BCUHB Pathology Contracts Manager and Blood Sciences Service Manager, supported by Procurement Services.
II.3) Dyddiad amcangyfrifedig ar gyfer cyhoeddi’r hysbysiad contract:
10/07/2026
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
This is a Provider Selection Regime (PSR) Intended Approach Notice. The contract is subject to The Health Services (Provider Selection Regime) (Wales) Regulations 2025 and is intended to be awarded using the Most Suitable Provider Process. Award decisions will be made by the BCUHB Pathology Contracts Manager and Blood Sciences Service Manager, supported by Procurement Services.
(WA Ref:166787)
VI.5) Dyddiad anfon yr hysbysiad hwn
19/06/2026